Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
ABSTRACT The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (CRISPR/Cas9) system, an RNA-guided DNA targeting technology, is triggering a revolution in the field of biology. CRISPR/Cas9 has demonstrated great potential for genetic manipulation. In this review,...
Main Authors: | Jiangtao Ren, Yangbing Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-04-01
|
Series: | Protein & Cell |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s13238-017-0410-x |
Similar Items
-
Increasing the safety and efficacy of chimeric antigen receptor T cell therapy
by: Hua Li, et al.
Published: (2017-04-01) -
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
by: Sasan Ghaffari, et al.
Published: (2021-08-01) -
Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing
by: Jie Liu, et al.
Published: (2019-03-01) -
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
by: Xingliang Guo, et al.
Published: (2018-10-01) -
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T
by: Dok Hyun Yoon, et al.
Published: (2018-01-01)